| Description: |
Pramipexole (Mirapex, Mirapexin, Sifrol) is a dopamine agonist of the non-ergoline class indicated For treating early-stage Parkinson's disease (PD) and restless legs syndrome (RLS). It is also sometimes used off-label as a treatment For cluster headache and to counteract problems with sexual dysfunction experienced by some users of selective serotonin reuptake inhibitor (SSRI) antidepressants. Pramipexole has shown robust effects on pilot studies in a placebo-controlled proof of concept study in bipolar disorder. It is also being investigated For the treatment of clinical depression and fibromyalgia. For the detailed information about the solubility of Pramipexole dihydrochloride in water, the solubility of Pramipexole dihydrochloride in DMSO, the solubility of Pramipexole dihydrochloride in PBS buffer, the animal experiment（test） of Pramipexole dihydrochloride,the in vivo,in vitro and clinical trial test of Pramipexole dihydrochloride,the cell experiment（test） of Pramipexole dihydrochloride,the IC50, EC50 and Affinity of Pramipexole dihydrochloride, please contact DC Chemicals. |
